275 related articles for article (PubMed ID: 30848956)
21. Recent discoveries in the molecular genetics of Lynch syndrome.
Boland CR
Fam Cancer; 2016 Jul; 15(3):395-403. PubMed ID: 27038793
[TBL] [Abstract][Full Text] [Related]
22. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.
Boland CR; Koi M; Chang DK; Carethers JM
Fam Cancer; 2008; 7(1):41-52. PubMed ID: 17636426
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair deficiency testing in clinical practice.
Buza N; Ziai J; Hui P
Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
[TBL] [Abstract][Full Text] [Related]
24. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.
Takeda T; Tsuji K; Banno K; Yanokura M; Kobayashi Y; Tominaga E; Aoki D
J Gynecol Oncol; 2018 May; 29(3):e29. PubMed ID: 29400022
[TBL] [Abstract][Full Text] [Related]
25. Current clinical topics of Lynch syndrome.
Tanakaya K
Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
[TBL] [Abstract][Full Text] [Related]
26. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
27. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
[TBL] [Abstract][Full Text] [Related]
28. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
Hall MJ
J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
[TBL] [Abstract][Full Text] [Related]
29. Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
Song Y; Loomans-Kropp H; Baugher RN; Somerville B; Baxter SS; Kerr TD; Plona TM; Mellott SD; Young TB; Lawhorn HE; Wei L; Hu Q; Liu S; Hutson A; Pinto L; Potter JD; Sei S; Gelincik O; Lipkin SM; Gebert J; Kloor M; Shoemaker RH
J Natl Cancer Inst; 2024 Jun; 116(6):957-965. PubMed ID: 38466935
[TBL] [Abstract][Full Text] [Related]
30. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
Nallamilli BRR; Hegde M
Curr Protoc Hum Genet; 2017 Jul; 94():10.12.1-10.12.23. PubMed ID: 28696559
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
32. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
33. [Comprehensive application of various screening strategies of Lynch syndrome].
Gao XH; Zhang W; Liu LJ; Yan HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):684-688. PubMed ID: 31302970
[TBL] [Abstract][Full Text] [Related]
34. [Lynch syndrome: What is new?].
Pellat A; Netter J; Perkins G; Cohen R; Coulet F; Parc Y; Svrcek M; Duval A; André T
Bull Cancer; 2019; 106(7-8):647-655. PubMed ID: 30527816
[TBL] [Abstract][Full Text] [Related]
35. Simplified identification of Lynch syndrome: a prospective, multicenter study.
Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
[TBL] [Abstract][Full Text] [Related]
36. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
37. Next Generation Sequencing in Molecular Diagnosis of Lynch Syndrome - a Pilot Study Using New Stratification Criteria.
Kašubová I; Holubeková V; Janíková K; Váňová B; Sňahničanová Z; Kalman M; Plank L; Lasabová Z
Acta Medica (Hradec Kralove); 2018; 61(3):98-102. PubMed ID: 30543514
[TBL] [Abstract][Full Text] [Related]
38. Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test.
Alqahtani M; Grieu F; Carrello A; Amanuel B; Mashour M; Alattas R; Alsaleh K; Alsheikh A; Alqahtani S; Iacopetta B
Asian Pac J Cancer Prev; 2016; 17(4):1917-23. PubMed ID: 27221876
[TBL] [Abstract][Full Text] [Related]
39. [Lynch syndrome in the hands of pathologists].
Daum O; Beneš Z; Hadravský L; Stehlík J; Cerná K; Dušek M; Kokošková B; Michal M
Cesk Patol; 2014 Jan; 50(1):18-24. PubMed ID: 24624982
[TBL] [Abstract][Full Text] [Related]
40. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
